Sign Out
Symptoms: Expected symptoms are those of excessive β-adrenergic stimulation, the most prominent being tachycardia, palpitation, tremor, hypertension, hypotension, widening of the pulse pressure, anginal pain, arrhythmias, and flushing.
Metabolic acidosis has also been observed with fenoterol when applied in doses higher than recommended for the approved indications of BEROTEC.
Treatment: Treatment with BEROTEC should be discontinued. Acid base and electrolyte monitoring should be considered.
Administration of sedatives, tranquilizers and in severe cases, intensive therapy may be needed.
Beta-receptor blockers, preferably β1-selective, are suitable as specific antidotes; however, a possible increase in bronchial obstruction must be taken into account and the dose should be adjusted carefully in patients suffering from bronchial asthma.
